Want to join the conversation?
$BIIB and $IONS said $BIIB closed rolling submission of a New Drug Application (NDA) to the FDA for approval of nusinersen, an investigational treatment for spinal muscular atrophy (SMA). $BIIB has also applied for Priority Review which, if granted, would shorten the review period of nusinersen after the Agency's acceptance of the NDA.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.